Analysis on the clinical and pathological features and prognosis of familial gastric cancer in South China population: A single-center study of 724 patients

Journal of Oncology

Volumn , Issue , 2012, Pages

  Lu, Jun ^a   Huang, Chang Ming ^a   Zheng, Chao Hui ^a   Li, Ping ^a   Xie, Jian Wei ^a   Wang, Jia Bin ^a   Lin, Jian Xian ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CHINA; CLINICAL FEATURE; DISEASE SEVERITY; FAMILIAL CANCER; FAMILIAL GASTRIC CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POST TREATMENT SURVIVAL; RETROSPECTIVE STUDY; STOMACH CANCER; SURVIVAL RATE;

EID: 84870219150     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/641218     Document Type: Article

References (19)

1. Corso G., Marrelli D., Roviello F., Familial gastric cancer: update for practice management. Familial Cancer 2011 10 2 391 396 2-s2.0-79958083980 10.1007/s10689-010-9410-1
2. Wang B., Li Z., Liu C., Xu H., Jin F., Lu P., Family history of cancer in Chinese gastric cancer patients. Chinese-German Journal of Clinical Oncology 2010 9 6 321 326 2-s2.0-77956212947 10.1007/s10330-010-0621-6
3. Oliveira C., Seruca R., Carneiro F., Genetics, pathology, and clinics of familial gastric cancer. International Journal of Surgical Pathology 2006 14 1 21 33 2-s2.0-32344433111 10.1177/106689690601400105 (Pubitemid 43221612)
4. Humar B., Guilford P., Hereditary diffuse gastric cancer: A manifestation of lost cell polarity. Cancer Science 2009 100 7 1151 1157 2-s2.0-67449093573 10.1111/j.1349-7006.2009.01163.x
5. Guilford P., Humar B., Blair V., Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice. Gastric Cancer 2010 13 1 1 10 2-s2.0-77954673384 10.1007/s10120-009-0531-x
6. Park J. G., Yang H. K., Kim W. H., Caldas C., Yokota J., Guilford P. J., Report on the first meeting of the International Collaborative Group on Hereditary Gastric Cancer. Journal of the National Cancer Institute 2000 92 21 1781 1782 2-s2.0-0034329587
7. Caldas C., Carneiro F., Lynch H. A. T., Familial gastric cancer: overview and guidelines for management. Journal of Medical Genetics 1999 36 873 880 (Pubitemid 30003842)
8. Ebert M. P. A., Malfertheiner P., Review article: pathogenesis of sporadic and familial gastric cancer-implications for clinical management and cancer prevention. Alimentary Pharmacology and Therapeutics 2002 16 6 1059 1066 2-s2.0-0035999138 10.1046/j.1365-2036.2002.01288.x (Pubitemid 34680747)
9. Frank T. S., Hereditary cancer syndromes. Archives of Pathology & Laboratory Medicine 2001 125 85 90 (Pubitemid 32096190)
10. Guilford P., Hopkins J., Harraway J., McLeod M., McLeod N., Harawira P., Taite H., Scoular R., Miller A., Reeve A. E., E-cadherin germline mutations in familial gastric cancer. Nature 1998 392 6674 402 405 2-s2.0-0032568370 10.1038/32918 (Pubitemid 28168738)
11. Barber M., Fitzgerald R. C., Caldas C., Familial gastric cancer-Aetiology and pathogenesis. Best Practice & Research 2006 20 4 721 734 2-s2.0-33748680082 10.1016/j.bpg.2006.03.014 (Pubitemid 44391329)
12. Yamada H., Shinmura K., Ito H., Germline alterations in the CDH1 gene in familial gastric cancer in the Japanese population. Cancer Science 2011 102 10 1782 1788
13. Shinmura K., Kohno T., Takahashi M., Familial gastric cancer: clinicopathological characteristics. RER phenotype and geIInIine p53 and E-cadherin mutations. Carcinogenesis 1999 20 1127 1131 (Pubitemid 29263762)
14. Kaurah P., MacMillan A., Boyd N., Senz J., De Luca A., Chun N., Suriano G., Zaor S., Van Manen L., Gilpin C., Nikkel S., Connolly-Wilson M., Weissman S., Rubinstein W. S., Sebold C., Greenstein R., Stroop J., Yim D., Panzini B., McKinnon W., Greenblatt M., Wirtzfeld D., Fontaine D., Coit D., Yoon S., Chung D., Lauwers G., Pizzuti A., Vaccaro C., Redal M. A., Oliveira C., Tischkowitz M., Olschwang S., Gallinger S., Lynch H., Green J., Ford J., Pharoah P., Fernandez B., Huntsman D., Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. Journal of the American Medical Association 2007 297 21 2360 2372 2-s2.0-34249989159 10.1001/jama.297.21.2360 (Pubitemid 46883749)
15. Charlton A., Blair V., Shaw D., Parry S., Guilford P., Martin I. G., Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut 2004 53 6 814 820 2-s2.0-2442698759 10.1136/gut.2002.010447 (Pubitemid 38662130)
16. Rogers W. M., Dobo E., Norton J. A., Van Dam J., Jeffrey R. B., Huntsman D. G., Kingham K., Chun N., Ford J. M., Longacre T. A., Risk-reducing total Gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications. American Journal of Surgical Pathology 2008 32 6 799 809 2-s2.0-46249087094 10.1097/PAS.0b013e31815e7f1a
17. Yan-Wei Y. E., Rui-Zheng D., Ye Z., Prognostic analysis of familial gastric cancer in Chinese population. Journal of Surgical Oncology 2011 104 1 76 82
18. Lewis F. R., Mellinger J. D., Hayashi A., Lorelli D., Monaghan K. G., Carneiro F., Huntsman D. G., Jackson C. E., Caldas C., Prophylactic total gastrectomy for familial gastric cancer. Surgery 2001 130 4 612 619 2-s2.0-0034792297 10.1067/msy.2001.117099 (Pubitemid 32964606)
19. Chun Y. S., Lindor N., Smyrk T. C., Germline E-Cadherin gene mutations. Is prophylactic total gastrectomy indicated? Cancer 2001 92 181 187 (Pubitemid 32623055)